Dow Up 0.00% Nasdaq Up 0.09%

Immunomedics Inc. (IMMU)

-NasdaqGM
4.13 Up 0.01(0.24%) Nov 28, 1:00PM EST
Prev Close:4.12
Open:4.10
Bid:2.63 x 100
Ask:N/A
1y Target Est:7.67
Beta:-0.11
Next Earnings Date:N/A
Day's Range:4.10 - 4.36
52wk Range:3.04 - 6.17
Volume:662,610
Avg Vol (3m):696,060
Market Cap:384.64M
P/E (ttm):N/A
EPS (ttm):-0.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMMU

Comparison

Symbol% ChgMkt Cap
IMMUUp 0.24%384.64M
BIIBUp 0.91%72.66B
GSKDown 0.15%111.67B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):83.13
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.52
Quarterly EPS Est (Dec-14) :-0.13
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback